🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 657.57 -0.6% NASDAQ 100: 590.86 -0.7% Dow Jones: 459.32 -0.8%

Legend Biotech Corporation

LEGN Healthcare
$18.13 $-0.08 (-0.44%)
Market Cap: $3.35 B
Gurus Holding
4
Popularity Rank
#2315
% of Shares Held
1.76%
Net Activity (Q4 2025)
+$51.2 M

Guru Ownership Trend

Guru Analysis for Legend Biotech Corporation (LEGN)

Legend Biotech Corporation (LEGN), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $58.94 M.

Top institutional holders include Steven Cohen and Renaissance Technologies.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $51.2 M net inflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies reduced exposure by 52.2%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$60.77 M
Total Buy Value
New Buys 2
Additions 1
-$9.57 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
3

FAQs for Legend Biotech Corporation (LEGN)

Major holders include Steven Cohen ($60.54 M), Renaissance Technologies ($8.76 M), Paul Tudor Jones ($1.16 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 3.25 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $51.2 M, with 3 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited LEGN. The total reported sell value was $9.57 M.

Yes, 2 managers opened new positions in LEGN, and 1 increased their existing holdings. The total reported buy value was $60.77 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.07% New Buy 2,784,806 $60.54 M Q4 2025
0.01% Reduce -52.2% 402,800 $8.76 M Q4 2025
0.00% Add 1.2% 53,300 $1.16 M Q4 2025
0.00% New Buy 10,000 $217,400 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form